Drug Delivery Device Market to 2017 - Metered Dose Inhalers and Infusion Pumps to be Key Revenue Generators

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) September 9, 2011 --

The global market for drug delivery devices is forecast to exceed $22 billion by 2017 with a Compounded Annual Growth Rate (CAGR) of 4% from 2010 to 2017. Metered dose inhaler devices and the infusion systems market will be the largest drug delivery device segments, accounting for more than 96% of the total revenues. These categories are expected to grow at 4% and 6% CAGR during 2010 to 2017 to reach $13 billion and $8.3 billion respectively. The global drug delivery device market will be driven by new technological advancements, a shift towards needle-free technology and the adoption of cost cutting measures such as increased automation in the infusion system market. Furthermore, an increased level of control, accuracy and precision in infusion systems has led to a reduction in medication errors, thereby increasing market growth. The huge population afflicted with respiratory disorders such as asthma and chronic obstructive pulmonary disease will drive the metered dose inhaler market. Furthermore, according to the Asthma and Allergy Foundation of America, an estimated US population of 20 million suffers from asthma providing a huge opportunity for the growth of the drug delivery device market. Moreover, a growing number of clinical situations now demand a more sophisticated delivery system for effective treatment. In addition, a limitation of oral delivery is that the dosage is systemic rather than directed to a particular organ and the drug concentration is only at the optimal level in the body for a limited time. This need for specialized drug delivery devices for new drugs and therapeutics will lead to the
growth of drug delivery device market.

For Sample Pages, please click or add the below link to your browser:
http://gbiresearch.com/RequestSamplePages.aspx?ID=Drug-Delivery-Devices-to-2017-Metered-Dose-Inhalers-and-Infusion-Pumps-to-be-Key-Revenue-Generators&Title=Medical_Devices&ReportType=Industry_Report&CompanyID=fprco

In 2010, GlaxoSmithKline plc, with a 26% share was the leader in the global drug delivery device market, followed by Boehringer Ingelheim and AstraZeneca International plc each with 8%. The other significant players in this market are Hospira Inc with a 6% share and CareFusion Corporation with 5%. These important players have launched advanced drug delivery products which have enabled them to strengthen their market presence. The market dominance of GlaxoSmithKline plc can be attributed to its major presence in the metered dose inhaler device market; the largest category in the drug delivery device market. The large patient pool suffering from respiratory disorders such as asthma, obstructive lung disorders, cystic fibrosis, pulmonary arterial hypertension, COPD and infectious pulmonary disease will provide huge opportunities for the companies. Furthermore, the improved efficacy of pressurized metered dose inhalers for administering bronchodilator aerosols to mechanically ventilated patients has accelerated market growth.

GBI Research’s report, “Drug Delivery Device Market to 2017 - Metered Dose Inhalers and Infusion Pumps to be Key Revenue Generators” provides key data, information and analysis on the global drug delivery device market. The report provides the market landscape, competitive landscape and market trend information on four drug delivery device market categories, namely central venous catheters, infusion systems, metered dose inhaler devices and needle-free injections. The report provides comprehensive information on the key trends affecting these categories and key analytical content on the market dynamics. The report also reviews the competitive landscape and gives a detailed analysis of the pipeline products in each category. The report also reviews the details of important merger and acquisition deals that have taken place in the drug delivery device market during the past four years. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

For further details, please click or add the below link to your browser:
http://gbiresearch.com/Report.aspx?ID=Drug-Delivery-Devices-to-2017-Metered-Dose-Inhalers-and-Infusion-Pumps-to-be-Key-Revenue-Generators&ReportType=Industry_Report&coreindustry=ALL&Title=Medical_Devices&CompanyID=fprco

Visit our report store: http://www.gbiresearch.com

For more details contact:
pressreleases@gbiresearch.com
North America: +1 646 395 5477
Europe: +44 207 753 4299
+44 1204 543 533
Asia Pacific: +91 40 6616 6782

device market     drug delivery     medical devices